| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―23 |
The Role and Implications of COVID-19 in Incident and Prevalent Heart Failure |
Juan Simon Rico-Mesa, Justin Haloot, B. K. Anupama, Suman Atluri, Jing Liu, Umair Khalid |
| 2 |
[GO] |
2023―Sep―04 |
Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients |
Paolo Severino, Silvia Prosperi, Andrea D’Amato, Claudia Cestiè, Vincenzo Myftari, Viviana Maestrini, Lucia Ilaria Birtolo, Domenico Filomena, Marco Valerio Mariani, Carlo Lavalle, Roberto Badagliacca, Massimo Mancone, Francesco Fedele, Carmine Dario Vizza |
| 3 |
[GO] |
2023―Aug―01 |
Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies |
Elizabeth A. V. Jones |
| 4 |
[GO] |
2022―Sep―27 |
Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic |
Luke R. Gagnon, Chandu Sadasivan, Haran Yogasundaram, Gavin Y. Oudit |
| 5 |
[GO] |
2021―Apr―22 |
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation |
Gregorio Zaccone, Daniela Tomasoni, Leonardo Italia, Carlo Mario Lombardi, Marco Metra |
| 6 |
[GO] |
2021―Mar―05 |
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review |
Jonathan S. Gordon, Mark H. Drazner |
| 7 |
[GO] |
2020―Oct―06 |
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia |
Milo Gatti, Emanuel Raschi, Elisabetta Poluzzi, Cristian Martignani, Stefania Salvagni, Andrea Ardizzoni, Igor Diemberger |
|
